Close

Cyprus Professor Finds Fusion of Delta And Omicron Variant

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Axtria Scales Forward Deployed Engineering Team to 1,000 Experts

Global data analytics provider Axtria Inc. announced plans on...

FDA Releases Proposed Commitment Letter for Next Generic Drug User Fee Agreement

Following months of negotiations with industry stakeholders, the US...

Buying Guide: How to Source High-Quality Selank for Research

Peptide research continues to expand across academic and independent...
- Advertisement -

As per the Bloomberg News report on Saturday, January 8, Leondios Kostrikis, who is a professor in biological sciences at the University of Cyprus, the country has a new strain of COVID-19 which is a fusion of delta and omicron. According to her, Cyprus has already seen infections from Delta & Omicron and it is now seeing certain infections that are a combination of both. Bloomberg reports that this discovery is called deltacron since it has omicron-like genetics identification which is within the delta genomes.

The professor along with the team has identified around 25 cases wherein the statistical analysis shows that the frequency of the combined infections is higher in patients who have been hospitalized due to COVID-19 vis-à-vis other non hospitalized patients. The sequences of all the deltacron cases have now been sent to GISAID which is an international database that ensures to track changes in the virus.

Kostrikis adds that they will have to wait and watch if the new strain is pathological, contagious, or will prevail over the other viruses. But as per his personal views, the new strain may displace the highly contagious omicron variant.

The new deltacron has arrived as the existing omicron variant continues to spread at a brisk pace, which is causing a surge in cases across Europe and the US. In the US alone, there is an average of 600,000 cases a week for the last seven days.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Latest stories

Related stories

Axtria Scales Forward Deployed Engineering Team to 1,000 Experts

Global data analytics provider Axtria Inc. announced plans on...

FDA Releases Proposed Commitment Letter for Next Generic Drug User Fee Agreement

Following months of negotiations with industry stakeholders, the US...

Buying Guide: How to Source High-Quality Selank for Research

Peptide research continues to expand across academic and independent...

CSPC Pharmaceutical and AstraZeneca form Biologics Joint Venture

CSPC Pharmaceutical and AstraZeneca have signed a joint venture...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »